Crystal structure of adenosine A(2A) receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction

The G(s) protein-coupled adenosine A(2A) receptor (A(2A)AR) represents an emerging drug target for cancer immunotherapy. The clinical candidate Etrumadenant was developed as an A(2A)AR antagonist with ancillary blockade of the A(2B)AR subtype. It constitutes a unique chemotype featuring a poly-subst...

Descripción completa

Detalles Bibliográficos
Autores principales: Claff, Tobias, Schlegel, Jonathan G., Voss, Jan H., Vaaßen, Victoria J., Weiße, Renato H., Cheng, Robert K. Y., Markovic-Mueller, Sandra, Bucher, Denis, Sträter, Norbert, Müller, Christa E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235125/
https://www.ncbi.nlm.nih.gov/pubmed/37264098
http://dx.doi.org/10.1038/s42004-023-00894-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235125/
https://www.ncbi.nlm.nih.gov/pubmed/37264098
http://dx.doi.org/10.1038/s42004-023-00894-6

Ejemplares similares